MRI-based analysis of the natalizumab therapeutic window in multiple sclerosis.

Grimaldi, Luigi M E; Prosperini, Luca; Vitello, Gaetano; Borriello, Giovanna; Fubelli, Federica; Pozzilli, Carlo

Grimaldi, Luigi M E; Prosperini, Luca; Vitello, Gaetano; Borriello, Giovanna; Fubelli, Federica; Pozzilli, Carlo.

Affiliation

Grimaldi LM; UO Neurology, Multiple Sclerosis Centre, Fondazione Istituto San Raffaele G. Giglio, Italy.

Mult Scler ; 18(9): 1337-9, 2012 Sep.

Article in En | MEDLINE | ID: mdl-22389413

Subject(s)

Antibodies, Monoclonal, Humanized/administration & dosage; Brain/drug effects; Brain/pathology; Immunologic Factors/administration & dosage; Magnetic Resonance Imaging; Multiple Sclerosis, Relapsing-Remitting/drug therapy; Multiple Sclerosis, Relapsing-Remitting/pathology; Adolescent; Adult; Chi-Square Distribution; Drug Administration Schedule; Female; Humans; Infusions, Parenteral; Linear Models; Logistic Models; Male; Medication Adherence; Natalizumab; Odds Ratio; Predictive Value of Tests; Time Factors; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain / Magnetic Resonance Imaging / Multiple Sclerosis, Relapsing-Remitting / Antibodies, Monoclonal, Humanized / Immunologic Factors Type of study: Etiology_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Female / Humans / Male Language: En Journal: Mult Scler Journal subject: NEUROLOGIA Year: 2012 Document type: Article Affiliation country: Italy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google